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Chronic rhinosinusitis (CRS) determines irreversible alterations of the nasal mucosa with consequent impairment of ciliary movements and, therefore, mucociliary clearance (MCC). People of all ages can be affected by CRS but the elderly are subjects at the highest risk. CRS in the elderly with an age-related physiological impairment of nasal respiratory function, often accompanied by other chronic diseases, requires additional therapies to be added to the numerous daily medications. Since the currently available therapies for CRS include the use of drugs that can have adverse effects and contraindications, crenotherapy could represent a therapeutic option. Indeed, because the adverse effects and contraindications of crenotherapy are scarce, it can be safely used in elderly patients with comorbidities. The aim of this study is to evaluate the nasal cytological assessment after crenotherapy in elderly subjects with CRS. Two groups, comprising a total of 84 elderly subjects with CRS, were treated with crenotherapy with sodium chloride sulphate hyperthermal water rich in mineral salts (group I, n=49) and saline solution (group II n=35). Cytological assessment for both groups took place at baseline (TO) and. 1 month after treatment (T30). At T30 the nasal cytological assessment showed statistically significant improvements in the ciliary motility and in the count of neutrophils and spores in group I, but not in group II. Conversely, there were no significant differences in the count of eosinophils, mast cells, bacteria and biofilm in either group. Our data for the first time focused on the role of crenotherapy in the improvement of cytological assessment of CRS in the elderly.
Chronic rhinosinusitis (CRS) afflicts people of all ages and represents the most common causes of consultation with the primary care physician (1) . People of all ages can be affected by CRS, but children, the elderly, diabetics, heart patients, and immunocompromised patients suffering from chronic lower respiratory tract diseases are at the highest risk (2) . Recently, the incidence of rhinosinusitis has been progressively increasing and, in particular, an increase has been observed in chronic and recurrent forms in which the presence of anatomical abnormalities, infections, allergy, and other systemic diseases playa crucial role (3). All these factors determine irreversible alterations of the nasal mucosa with consequent impairment of ciliary movement and, therefore, of mucociliary clearance (MCC). MCC is the first line defense strategy against pathogens, toxins or other irritants, and depends on the integrity of the respiratory epithelium, which plays an important role both in innate and in adaptive immunity. From a cellular point ofview, CRS affects the ciliated cells, determining a rearrangement of the respiratory epithelium in favor of mucoussecreting cells, mucous-secreting metaplasia. This process has important pathophysiological and clinical consequences. Indeed, the mucous-secreting metaplasia causes a major production of mucous, whereas the decrease in number of ciliated cells leads to a reduced efficiency of the muco-ciliated transport. These events promote the stasis of mucous secretions in the nose and determine a major risk of bacterial infection. Since the turnover of a ciliated cell takes about three weeks, frequent inflammation does not allow the re-establishment of a normal ratio between the different cellular subsets (4-6).
The currently available therapies for CRS include corticosteroids, general or topical antibiotics, cromoglycate sodium, ipratropium bromide, and, more recently, sodium hyaluronate (1, 7). However, despite yielding encouraging therapeutic outcomes, almost all of these drugs can cause adverse effects and contraindications.
CRS in the elderly affected by an age-related physiological impairment of nasal respiratory function and chronic comorbidities requires additional therapies to be added to the numerous daily medications. Such therapeutic scenario will eventually worsen a patient's quality of life, as well as hislher already compromised health status.
Therefore, hoping to minimize the intake of additional drugs especially in elderly patients with comorbidities, clinicians are nowadays constantly searching for agents able to regenerate the respiratory mucosa and to prevent a worsening of CRS.
Crenotherapy, the therapeutic role of which is still debated in the literature, could represent a valid therapeutic option. Indeed, because adverse effects and contraindications are scarce, it can be safely used in elderly patients with comorbidities (7) (8) (9) (10) (11) . Apparently, crenotherapy acts as an antiinflammatory, a mucolytic, and a mucus and trophic regulator, thereby boosting the body's immune defenses (7) (8) (9) (10) (11) . In particular, it induces vasodilatation and capillary permeability, stimulates the synthesis of IgAs, and reduces serum and tissue levels of IgE, thereby improving mucociliary clearance (7) (8) (9) (10) (11) . Notwithstanding these results, the efficacy of crenotherapy in the treatment of CRS still remains unclear.
This study aims to evaluate for the first time the effect ofcrenotherapy with sodium chloride sulphate hyperthermal water rich in mineral salts on the nasal cytological assessment in elderly subjects with CRS.
MATERIALS AND METHODS
The study involved 84 subjects suffering from CRS and took place in the ENT unit of the Department of Neuroscience, Federico II University of Naples, Italy.
CRS diagnosis, based on the European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS) diagnostic criteria at baseline, was further confirmed by nasal endoscopy and computed tomography (CT) scans (12) . Nasal endoscopy with a 2.7-mm 30-degree rigid endoscope (Storz, Tuttlingen, Germany) was performed without decongestant or local anesthesia.
Exclusion criteria were the following: age less than 65 years, smoking habit, acute infections, fever, heart diseases, neurological diseases, cancer diseases, allergies, severe systemic diseases, immunodeficiency, and psychogenic cough. Subjects who were being treated with antitussives, antibiotics, steroids, antihistamines, local vasoconstrictive decongestants and/or local steroids were also excluded.
The study was approved by the local Board ofMedical Ethics. Written informed consent was obtained from all participants prior to inclusion in the study.
The subjects, divided into 2 groups, were all treated at the Thermae Oriente, Ischia, Italy. Group I, the investigational arm, consisting of elderly subjects with CRS, underwent crenotherapy with sodium chloride sulphate hyperthermal water rich in mineral salts (Table  I) . In brief, patients received steam inhalation for 10 min, then rested for 10 min, and finally received aerosol for another 10 min for 12 consecutive days. Instead, group II, the control arm, underwent inhalation and aerosol with isotonic saline solution NaCI 0.9% alone, according to the same protocol.
Individual steam hot-vapor inhalation was administered at 38°C, 20 em from the face, whereas individual aerosol was administered in a different room with a nasal adapter using the same type ofwater (mineral water for group I and NaCI 0.9% solution for group II) at the same temperature. For the rest period, subjects were transferred into another room without thermal vapor.
ENT assessment and nasal cytology were carried out at different times: (i) at baseline (TO) and (ii) four weeks after the beginning oftreatment (T30), after an 18-day rest period to avoid the influence ofpossible thermal reactions (cough, dryness, increased secretions).
Nasal cytology was performed by anterior rhinoscopy. The scraping of the nasal mucosa was collected from the middle portion of the inferior turbinate using a Nasal Scraping" (IR MEDICAL, Lugo, RA, Italy) cytology curette. Samples were placed on a glass slide, fixed by air drying and stained according to the May-Grunwald Giemsa (IR MEDICAL, Lugo, RA, Italy) method and then observed by optical microscope (13) . The nasal cytological assessment, performed in blind condition by two investigators who were unaware ofthe assigned treatment, evaluated the presence and the number of neutrophils, eosinophils, mast cells, bacteria and fungi according to a 0-4 score (0 = absent, 1 = rare, 2 = some, 3 = easily visible, 4 = many) (13) . Ciliary motility was assessed on fresh samples by contrast-phase microscope according to a 0-3 score (0 = absent, 1 = < 5',2 = 2: 5' and:::: 10',3 = > 10'), where a higher value corresponds to a better motility (14) . After treatment, the subjects were asked to indicate their degree of tolerability on a scale from 1 to 3 (1 = sufficient, 2 = good, 3 = excellent) (13) (14) . Continuous baseline characteristics were presented as median or mean and standard deviation, where appropriate. We tested group differences with the Mann-Whitney U test, and considered P <0.05 to be statistically significant. Data were tabulated in a Microsoft Excel (Microsoft Corporation, Redmond, WA, USA) spreadsheet and imported into the Statistical Package for Social Sciences (SPSS-PC, version 16, SPSS Inc., Chicago, IL, USA).
RESULTS
Eighty-four elderly (35 M and 54 F, mean age 70.3±11) patients were enrolled in the study.
Subjects were divided into 2 groups: group I, the investigational arm, consisting of 49 elderly subjects with CRS undergoing crenotherapy with sodium chloride sulphate hyperthermal water rich in mineral salts, and group II, the control arm, consisting of 35 elderly patients with CRS undergoing steam hotvapor inhalation and aerosol with isotonic saline solution NaCl 0.9% alone, according to the same protocol.
At baseline, group I and group II were well matched for sex and age, and no statistically significant differences were observed in clinical and cytological parameters (Table II) . At T30, patients in both groups reported having no adverse reactions.
Remarkably, after treatment all the subjects in group I reported symptom improvements. Furthermore, at T30, significant improvements in the ciliary motility (30 min vs 20 min), count of neutrophils [0 (0-1) vs 2 (0-3)] and fungi [0 (0-0) vs 0 (0-1)] were observed in patients undergoing crenotherapy. Conversely, no significant differences in the count of eosinophils, mast cells, bacteria and in biofilm was observed (Table II) .
On the contrary, in the control group the nasal cytological assessment at TO and T30 was not statistically significant in any observed parameter.
Finally,the self-report questionnaire filled in after treatment to evaluate the patients' degree tolerability showed the same degree (IQR 3-3) in both groups (p>0.05).
DISCUSSION
Chronic inflammation of the nasal mucosa determines . irreversible alterations and rearrangements of the respiratory epithelium in favor of mucous-secreting cells. This process has relevant pathophysiological and clinical consequences, leading to an impairment ofthe MCC and an overproduction of mucina that promotes the bacterial replication. Impaired MCC then induces the development or the worsening of chronic diseases. On the other hand, the improvement of MCC protects the airways against organic and nonorganic agents, including microorganisms.
Although patients with CRS can experience some degree of recovery, the extent of improvement is still inconsistent in the literature. The currently available therapies for CRS involve the use of drugs often characterized by side effects and contraindications which inevitably worsen the already compromised generalhealthstatusof elderlypatients (1, 7) . For these reasons, clinicians nowadays are constantly searching for agents able to treat CRS and to promotethe MCC.
Crenotherapy, which is one of the oldest healing practices in medical history, could represent a valid therapeutic alternative. Indeed, anti-inflammatory and mucolytic actions are just two of several therapeutic properties of thermal water. Others include the regulation ofmucous membrane tropism, capillary permeability, synthesis of sIgA, and mucociliary clearance (8, 9) . However, the role of crenotherapy in the treatment of CRS is still largely underestimated (11) .
In this study, we evaluated for the first time the nasal cytological assessment in elderly patients with CRS after administration of crenotherapy with sodium chloride sulphate hyperthermal water rich in mineral salts and compared it to the nasal cytological assessment of a control group treated with only isotonic solution.
Remarkably, after treatment, MCC, together with the accompanying cytological parameters related to the presence offungi and neutrophils, were improved in group I, but not in group II (Table II) . Conversely, at T30, we did not observe statistically significant differences regarding the count of eosinophils, mast cells and bacteria, and the presence of biofilm in either group. Furthermore, none of the patients reported adverse reactions, and all reported a high degree of tolerability to the therapy. These findings focus on anti-inflammatory properties of thermal waters. Notably, the absence of statistically significant improvements in the count of eosinophils, mast cells, bacteria, and biofilm suggests some comments. Probably, elderly patients suffering from long-term CRS have structural rearrangements of the nasal mucosa (15) that require more than one therapeutic cycle. Moreover, additional genetic or molecular factors related to aging and not yet studied might aggravate the nasal cytological scenario in the elderly. Thus, further research is need in the field of molecular medicine.
All in all, we believe that crenotherapy with sodium chloride sulphate hyperthermal water rich in mineral salts represents a reliable approach to treating CRS in elderly subjects. Our study results suggest that in these patients crenotherapy should be used as a primary treatment. Indeed, its healing effect on the tissues underlying the pathological status can promote mucosal recovery. In addition, because crenotherapy is characterized by a high degree oftolerability, it can be safely used in patients with comorbidities. Moreover, because of the high incidence of these conditions, a substantial economic burden is imposed on society not only in terms of direct costs, but also in terms of indirect costs.
For all these reasons, we are adamant that crenotherapy deserves particular attention, especially in the field ofpreventive health care, health promotion and health education.
